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Abstract  
Extensive studies have revealed prominent anti-tumor actions of berberine, a small 
molecule derived from Coptidis Rhizoma (Huanglian in Chinese) and many other 
plants. To clarify the berberine induced cell death and underlying mechanisms in 
cancer cells, we examined autophagy and apoptosis in human hepatic carcinoma cells 
HepG2 and MHCC97-L. In the present study, the results showed that berberine can 
both induce autophagy and apoptosis in hepatocellular carcinoma cells. Cell viability 
of berberine in human hepatic carcinoma cells increased due in the presence of the 
cell death inhibitor, 3-Methyladenine or by interfering with the essential autophagy 
gene Atg5. Mechanistic studies showed that berberine may activate mitochondrial 
apoptosis in HepG2 and MHCC97-L cells via increasing Bax expression, permeability 
transition pore formation and cytochrome C release to the cytosol, and subsequent 
activation of the caspase-3 and caspase-9 execution pathway. Berberine may also 
induce autophagic cell death in HepG2 and MHCC97-L cells via activation of 
Beclin-1, but inhibition of the mTOR signaling pathway by suppressing the activity of 
Akt and up-regulating P38 MAPK signaling. This is the first time that contribution of 
the activation of Beclin-1 and inhibition of mTOR in the mechanism of 
berberine-induced autophagic cell death has been described. These results further 
demonstrate the potential of berberine as a therapeutic agent in the emerging list for 
cancer therapies with novel mechanisms. 
 
Key word: Berberine; autophagy; apoptosis; Bcl-2/Beclin-1; mTOR 
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Introduction 
 
Hepatocellular carcinoma (HCC), amounting for 80% to 90% of liver cancer, has 
become one of the most common and prevalent human malignancies in the world 
[Budhu et al., 2008].  However, effective therapy of this malignancy remains rare and poor. 
One of the important approaches for liver cancer treatment is chemotherapy, in which the 
main mechanism of chemotherapeutic agents is to cause cancer cell death. Several types of 
cell death have been classified and defined by the Nomenclature Committee on Cell Death 
(NCCD), including apoptotic and autophagic cell death. These two types of cell death, also 
known as Type I and Type II Programmed Cell Death (PCD) respectively, differ in 
morphological features and signal transduction but share the same result on cell death 
[Kroemer et al., 2009]. Apoptosis is considered as a conventional type of cell death whereas 
autophagic cell death is simply defined as cell death with autophagy, which process is also 
thought to be one of the mechanisms for cell survival [Galluzz et al., 2008]. Recently, 
extensive studies reported apoptosis and autopahgy were both involved in chemotherapeutic 
agents-induced cancer cell death [Cheng et al., 2009; Kim et al., 2009], suggesting that 
apoptosis and autophagy be important for illustrating the underlying mechanism for novel 
therapeutic agents.  
 
Berberine is a natural product derived from many kinds of herbs, like Coptidis Rhizoma 
(Huanglian in Chinese), Hydrastis canadensis, Berberis aquifolium, Berberis aristata and 
Berberis vulgaris (barberry). Many studies reported the in vitro and vivo anti-cancer effect of 
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Huanglian and berberine via different mechanisms [Tang et al., 2009]. Berberine may 
suppress cancer cells via regulating the cell cycle [Serafim et al., 2008], inhibiting the ATP 
generation [Pereira, 2007], or inducing cancer cell apoptosis [Pandey et al., 2008]. It was also 
reported that berberine could suppress cancer invasion and metastasis via regulating the 
HIF-1α activity in SC-M1 cells [Lin et al., 2004]. Recently, we found that anti-invasion of 
berberine may inhibit RhoA signaling pathway at low dose, while apoptosis are induced by 
berberine via G2 arrest at high dose due to berberine distribution in cell nuclear and 
cytoplasm in dose dependent manner [Tsang et al., 2009]. These illustrate the potential of 
berberine for cancer therapy. Previous study reported a synergistic induction of autophagic 
cell death by radiation and berberin  in lung cancer [Peng, et al., 2008], but there’s no study 
focusing on the induction of autophagy by single treatment of berberine. Moreover, no study 
reveals the contribution of different types of cell death on anticancer effect of berberine and 
their underlying signaling transduction. 
 
In this study, we reported for the first time that berberine induces both autophagic cell death 
and mitochondrial apoptosis in human hepatic carcinoma cells, HepG2 and MHCC97-L cells. 
Berberine showed potent cytotoxicity to various cancer cell lines including HepG2, 
MHCC97-L, HONE1, Hela and HK1. Berberine can induce mitochondria apoptosis in HepG2 
and MHCC97-L cells, shown as a decrease of mitochondria membrane potential and an 
increase of Bax expression as well as activation of caspase-3 and caspase-9. Berberine can 
also induce autophagy via activating Beclin-1 and inhibiting mTOR signal pathway in the 
same cancer cell lines. Inhibition of berberine on mTOR activity may result from both the 
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activation of P38 MAPK and suppression of Akt signaling. Inhibition of autophagy by 
3-methyladenine (3-MA) treatment or by silencing the autophagy protein 5 (Atg5) gene 
attenuates cell death induced by berberine, indicating that berberine-induced autophagy 
contributes to its anticancer effect. By integrating the underlying mechanism of cell death, our 
finding suggests that berberine, which initiates both apoptotic and autophagic cell death (Type 
I and Type II cell death), can be added to the list of emerging agents with potential for cancer 
therapy. 
 
Materials and Methods 
 
Chemical, plasmid and Antibodies  
Berberine hydrochloride, the autophagy-apoptosis inhibitor 3-methyladenine (3-MA) and 
autophagosome-lysosome fusion inhibitor bafilomycin A1 were purchased from 
Sigmaaldrich (USA). The pcDNA3 plasmid encoding human LC3 was kindly gifted by 
Professor Yoshimori. Anti- Bcl-2, anti-Bax, anti-caspase-3, anti-caspase-9, anti-Beclin-1, 
anti-β-actin, anti-phosphorylated mTOR, anti-mTOR, anti-phosphorylated AKT, anti-AKT 
and anti-COX-IV were purchased from Abcam (UK). Anti-LC3B was purchased from 
Novus Biologicals (USA). Anti-P38 MAPK, anti-phosphorylated P38 MAPK 
(Thr180/Tyr182) and anti-Atg5 were purchased from Cell Signaling Technology (USA). 
 
Cell line and Cell culture  
Human hepatocarcinoma cell line HepG2, human nasopharyngeal carcinoma cell line HONE1 
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and HK1 were purchased from ATCC (USA). Human liver cancer cell line with high 
metastatic property MHCC97-L was gifted from Professor Tang and had been used in our 
previous study [Lee et al., 2005]. Cells were maintained in Dulbecco's Modified Eagle 
medium with high glucose and incubated in a humidified atmosphere containing 5% CO2 at 
37 ℃. 
 
Cell viability assay  
MTT assay was introduced to detect the cytotoxicity of berberine in different cancer cells. In 
brief, cells were seeded in 96-well plate with DMEM medium (High glucose, supplemented 
with 10% FBS) with density of 10, 000 cells/well. A series of concentrations of berberine 
were added for 48 hr incubation. All experiments were conducted parallel with controls (0.1 
% DMSO). 15µl of 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT, 5 
mg/ml, Sigma, USA) were added to each well at the end of treatment and incubated at 37℃ 
for 4 hr. Then medium was removed and 200 µl DMSO was added to each well. The 
absorbance of formazan formed was measured at 595 nm by Multiskan MS microplate reader 
(Labsystems, Finland).  
 
Monodansylcadaverine & Acridine Orange staining  
Cells were seeded on cover slips and exposed to different concentration of berberine (50, 100 
or 200 µM in HepG2 cells and 100, 200 or 400 µM in MHCC97-L cells respectively) for 6 hr. 
For monodansylcadaverine (MDC) staining, cells were stained by 0.05 mM MDC in PBS at 
37 ℃ for 10 minutes [Munafó & Colombo, 2001]. After incubation, cells were washed with 
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PBS for four times and the cover slips were placed onto slides and visualized under 
fluorescent microscope (Carl Zeiss, USA). For Acridine Orange (AO) staining, cells were 
stained by 1 µg/mL AO in PBS at 37℃ for 15 minutes [Yang et al., 2008] followed by wash. 
Then the cover slips were placed onto slides and visualized under fluorescent microscope 
(Carl Ziess, USA, 63×, CCD camera). 
 
Quantification of GFP-LC3 puncta 
HepG2 cells were transfected with pcDNA3 plasmid encoding GFP-LC3 using lipofectamine 
2000 (Invitrogen, USA) in serum- and antibiotic-free medium for 6 hr followed by 72 hr 
incubation in growth medium. Then cells were selected with 1 mg/mL G418 (Gibico, USA) to 
establish a cell line stably expressing GFP-LC3 fusion protein. After that, cells were seeded 
into 35-mm confocal dishes and treated with 50, 100 or 200 µM of berberine for 6 h. The 
accumulation of GFP-LC3 was examined by fluorescence microscopy (Carl Ziess, USA, 63×, 
CCD camera). Autophagy was quantified by counting the percentage of cells showing 
accumulation of GFP-LC3 in dots. 100 cells per preparation in three independent experiments 
were calculated. Cells represent several intense punctuate GFP-LC3 aggreagates were 
classified as autophagic [Shen et al., 2010]. 
 
Annexin V/PI Double Staining  
HepG2 and MHCC97-L cells with treatment were collected using micro-scrapper (Corning, 
USA) and then centrifuged. To detect apoptosis in HepG2 and MHCC97-L cells after 
exposure to berberine, Annexin V/PI double staining kit (Sigma aldrich, USA) was introduced 
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to quantify cell amount in different stages of cell death [Vermes, et al., 1995]. Briefly, cells 
were re-suspended in 1 mL of binding buffer containing 100 mM HEPES/NaOH, 1.4 mM 
NaCl, 25 mM CaCl2, pH 7.5. Then 5 µl of FITC-conjugated Annexin V (50 µg/mL) and 10 µl 
of propidium iodide (100 µg/mL) were added and incubated in dark for exactly 10 minutes at 
room temperature and detected by flow cytometer (Epics XL, Beckman Coulter, USA).  
 
Detection of mitochondria membrane potential (MMP)  
The mitochondrial membrane potential probe, Rhodamine-123 (Rh-123) is used to 
qualitatively and quantitatively determine the decrease of MMP in HepG2 and MHCC97-L 
cells treated with serious doses of b rberine. For qualitative analysis, HepG2 and MHCC97-L 
cells were seeded into 30 mm confocal culture dishes with 40% confluence. Cells were 
treated with or without berberine (50, 100 or 200 µM in HepG2 cells and 100, 200 or 400 µM 
in MHCC97-L cells respectively) for 12 hr. After treatment, cells were washed with PBS and 
were stained with 1 µmol/L Rh-123 (Sigma, USA) for 25 minutes at room temperature in dark. 
Then cells were rinsed and visualized under fluorescent microscope (Carl Ziess, USA, 63×, 
CCD camera). For quantitative analysis of MMP in berberine treated cells, HepG2 or 
MHCC97-L cells were cultured in a 96-well black-botomed plate and treated with series 
concentrations of berberine for 12 hr. Cells were washed once with PBS and then incubated 
with Rh-123 (1 µmol/L) in PBS for 25 minutes. The fluorescence intensity in each well was 
then measured using a fluorescent microplate spectrometer (LS55, PerkinElmer) with 
excitation and emission wavelengths at 488 and 530 nm, respectively. 
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Measurement of Cytochrome C release 
Cells with or without treatment of berberine was harvested using a micro-scrapper (Corning, 
USA) and then cytoplasmic protein was extracted by NP-40 lysis buffer (Invitrogen, USA) 
supplemented with proteinase inhibitor (1% PMSF, 0.5%apotinin and 0.5% leupitine) on ice 
for 5 minutes followed by centrifugation at 14,000 rpm at 4℃ for 10 minutes. Supernatant 
was collected and protein concentration was determined. The release of cytochrome C (Cyto 
C) was monitored by immunobloting and COX-IV was used to monitor the cleavage of 
mitochondria fraction. 
 
Immunobloting  
cells with treatment were harvested using a micro-scrapper (Corning, USA) and then lysed 
with RIPA buffer supplemented with proteinase inhibitor (1% PMSF, 0.5%apotinin and 0.5% 
leupitine) and phosphatase inhibitor (1 mM Na3VO4 and 1mM NaF) on ice for 30 minutes and 
then centrifuged at 14,000 rpm at 4℃ for 25 minutes. The supernatant was transferred to a 
new tube and protein concentration was determined using BSA as a standard. Equal amounts 
of protein were resolved by SDS-PAGE and transferred onto a polyvinylidene fluoride 
membrane (PVDF, Biorad). Then the membrane was blocked with 5% BSA in buffer 
containing Tris (10 mmol/L, pH7.4), NaCl (150 mmol/L) and Tween 20 (1%) overnight at 
4℃. The membrane was then incubated with primary antibodies at 4℃ overnight followed by 
incubation with appropriate secondary antibody (Abcam, UK) at room temperature for 2 
hours. The immunoreactivites were detected using ECL advanced kit (GE Healthcare, UK) 
and visualized using a chemiluminenescence imaging system (Biorad, USA). 
Page 9 of 41
John Wiley & Sons, Inc.
Journal of Cellular Biochemistry
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
 10 
 
RNA interference  
HepG2 cells stably transfected with plasmid encoding GFP-LC3 were cultured in 35-mm 
confocal dishes for overnight. Then cells were transfected with siRNA against human ATG5 
(Santa Cruz, 1.25 µg/mL) using transfection reagent Lipofectamine 2000 (Invitrogen, USA) 
in serum- and antibiotic- free medium for 6 hr and then cultured in normal growth medium 
for 72 hr. Cells were then treated with 100 µM berberine for 6 hr and then visualized under 
fluorescent microscope (Carl Ziess, USA, 63×, CCD camera). 
 
Statistical analysis  
Results were analyzed using student T-test and expressed as mean ± SD. 
 
Results 
 
Berberine induce liver cancer cell death in vitro 
Berberine exhibits significant induction on the death of carcinoma cell lines including 
hepatocellular carcinoma cell HepG2, MHCC97-L, human cervical epithelioid carcinoma cell 
Hela, nasopharyngeal carcinoma cell HONE1 and HK1 according to MTT assay. The IC50 of 
berberine in different cancer cells varies because of different sensitivity of cancer cells to 
berberine. It can be found from the MTT results that MHCC97-L cells exhibit the highest 
resistance when exposed to berberine. The IC50 of berberine in HepG2 cells was 
approximately 100 µM after 48 hr treatment and MHCC97-L cells showed higher resistance 
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to berberine, which IC50 was at dose of 250µM (Fig.1A). Addition of 3-MA reduces 
berberine’s action on hepatocellular carcinoma cell viability (Fig.1B). Consistent result can be 
observed that silencing the Atg5 attenuates berberine induced hepatoma cell death (Fig.1C 
and 1D), indicating that autophagy may act as one of the mechanisms of anti-cancer action of 
berberine. 
 
Berberine induces autophagy and apoptosis in liver cancer cells  
Autophagy is a process that may function either as an approach for cell survival under certain 
circumstances or as a second type of programmed cell death (Type Ⅱ PCD) [Hsieh et al., 
2009]. In cell proceeding autophagy, cytoplasmic proteins are sequestrated into lytic 
components and is characterized by formation and prototion of Autophagic vacuole and acidic 
vacuole [Gao, et al., 2009]. MDC is a chemical probe that has been generally and widely used 
as a marker for autophgic avuoles because of its ability to show the accumulation of 
autophagic vacuoles in acidic compartments enriched in lipids [Bampton et al., 2005]. In our 
study, obviously increased staining intensity in cytoplasm in HepG2 and MHCC97-L cells 
could be observed in dose-dependent manner (Fig. 2A). Consistent results could be observed 
when cells treated with or without berberine were stained by acridine orange (AO), which is a 
specific fluorescent probe frequently used to stain lysosome [Moriyama et al., 1982]. Fig. 2B 
shows the accumulation of lysosome in cells treated with berberine. Moreover, addition of 
3-MA suppresses the formation of autophagosome and autolysosome (Fig. 2A and 2B). The 
increased expression of LC3-II bands could be detected in cells treated with berberine. These 
results indicated the induction of autophagy in liver cancer cells exposed to berberine. 
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Moreover, berberine’s property on inducing autophagy was further confirmed by the 
accumulation of GFP-LC3 fusion protein in HepG2 cells nucleofected with a pcDNA3 
plasmid encoding GFP-LC3 fusion protein (Fig. 2D). Quantification of GFP-LC3 puncta 
shows that berberine treatment induced dose-dependent puncta of autophagosome, and 
silencing the expression of Atg5 blocked the action of berberine (Fig. 2D, right).  Addiction 
of bafilomycin A1, an autophagosome-lysosome fusion inhibitor in combination with 
berberine exposure results in the significant decrease of LC3-I form (Fig. 2E), indicating that 
berberine is able to transfer the cytoplasmic form of LC3 into autophagysome form. These 
results demonstrated berberine’s property in inducing autophagy in hepatocellular 
carcinoma cells. 
 
To assess the other type of programmed cell death, apoptosis, in HepG2 and MHCC97-L cells 
treated by berberine, Annexin V/PI double-staining was introduced to this study. The results 
showed that berberine could significantly induce early and median apoptosis after 12 hr 
treatment (Fig. 3A). The induction of apoptosis by berberine was enhanced in dose- 
dependent manner (Fig. 3B). These results suggested that berberine could induce apoptosis 
but not necrosis in hepatocellular carcinoma cells.  
 
Loss of mitochondria membrane potential activates the mitochondrial cell apoptosis signal 
pathway in cells treated by berberine  
Dose-dependent dropping fluorescent signal could be observed in both HepG2 and 
MHCC97-L cells treated with different concentration of berberine when compared with 
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control group, indicating the loss of transmembrane potential induced by berberine in HepG2 
and MHCC97-L cells (Fig.4A and 4B). Immunoblotting study presented the overexpression 
of Bax, cleaved caspase-3 and caspase-9 after berberine treatment (Fig.4C), indicating that 
berberine could induce liver cancer cell apoptosis via mitochondrial cell death pathway in 
dose-dependent manner (Fig.4D).  
 
Inhibition of Bcl-2 expression and activation of Beclin-1 in the mitochondrial apoptosis 
and autophagy  
Bcl-2 is a member of Bcl-2 family, whose members share at least one Bcl-2 homology (BH) 
region in their structures. The Bcl-2 protein serves as an anti-apoptotic factor via stabilizing 
the mitochondria membrane and preventing pro-apoptotic factor releasing into cytosol 
[Levine et al., 2008]. Interestingly, extensive studies have found that Bcl-2 may also serve as 
an autophagy inhibitor via inhibiting the Beclin-1 expression in various kinds of cancer cells 
[Pattingre & Levine, 2001]. Beclin-1 was initially discovered as a Bcl-2-interacting protein 
and a positive regulator of autophagy induction in eukaryotic cells [Sun, et al., 2009]. 
Beclin-1 was also identified as a tumor suppressor in various kinds of cancers [Yue et al., 
2003; Qu et al., 2003; Liang et al., 1999], indicating its important role in autophagic cell death 
during cancer therapy. In this study, the expression of Bcl-2 was inhibited by berberine in 
HepG2 and MHCC97-L cells, and increasing Beclin-1 expression could be observed in cells 
exposed to different concentrations of berberine (Fig. 5). Moreover, the overexpression of 
Bax, a pro-apoptotic factor important for PT pore formation, showed an apparent 
mitochondrial apoptotic manner in HepG2 and MHCC97-L cells treated with berberine. 
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These results suggested that berberine could serve to activate Beclin-1 and Bax via 
suppressing the Bcl-2 expression. The activation of Beclin-1 and Bax, as a result, could 
induce both apoptotic cell death (Type I PCD) and autophagic cell death (Type II PCD) in 
hepatocellular carcinoma cells. 
 
Activation of P38 MAPK and inhibition of Akt signaling contribute to the mTOR inhibition 
by berberine and induce autophagy in hepatocellular carcinoma cells  
Mammalian target of rapamycin (mTOR) is a serine/threonine protein kinase involved in 
many processes in cells. Cell proliferation, migration and protein synthesis were reported by 
mTOR signaling [Hay & Sonenberg, 2004; Beever, et al., 2006]. The mTOR signaling was 
reported to negatively regulate autophagy and Inhibition of mTOR activity induces autophagy 
in some previous studies [Wang et al., 2009; Tang et al., 2007]. In this study, significant 
inhibition of mTOR activity by berberine treatment could be observed in both HepG2 and 
MHCC97-L cells in dose-dependent manner, indicating that mTOR suppression could 
contribute to the autophagy induction by berberine (Fig. 5A and 5B). Moreoever, sorts of 
signaling transduction have been found to regulate the activity of mTOR, including P38 
MAPK, MEK/Erk and Akt [Tang, et al., 2008; Wang et al., 2009; Bommareddy et al., 2009]. 
In this study, Akt inhibiton was observed in dose-dependent manner (Fig. 5A and 5B), 
revealing that Akt could function as a regulator of mTOR and autopahgy in berberine’s action. 
Furthermore, it is interesting to find that P38 MAPK was significantly activated by berberine 
in HepG2 cells but not in MHCC97-L. With the observation that mTOR signaling inhibition 
in MHCC97-L cells was not as significant as in HepG2 cells, this finding indicated that a 
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cell-type difference in the regulation of P38 MAPK activity by berberine may affect its action 
on mTOR activity (Fig. 5A and 5B). 
 
Discussion and Conclusion 
 
With a long history of clinical use in both Chinese and Ayurvedic medicine, berberine has 
been conventionally used for the treatment of infectious diseases including bacterial diarrhea, 
intestinal parasite infections, and ocular trachoma infections regarding its prominent 
anti-microbial activity against bacteria, viruses, fungi, protozoans, helminths, and chlamydia 
[Birdsall & Kelly, 1997]. Extensive studies also reported berberine’s action on cancer in vitro 
and in vivo, including anti-proliferation, G2/M cell cycle arrest and apopotosis induction of 
HepG2, however, the underlying mechanism of berberine-induced cancer cell death is not 
fully revealed yet [Tang et al., 2009]. The nonsteroidal anti-inflammatory drug 
(NSAID)-activated gene (NAG-1) was reported as the molecular target of berberine on 
HepG2 [Auyeung & Ko, 2009]. In the present study, we tried to draw a more comprehensive 
illustration on berberine-induced cell death including apoptosis and autophagy in cancer cells 
by using hepatocellular carcinoma cell models. Berbeirne induced Bax activation in HepG2 
and MHCC97-L followed by the formation of PT pore and reduction of mitochondrial 
membrane potential, and allowed Cyto C to release from mitochondria to cytosol. The 
subsequent activation of caspase signal pathway resulted in apoptosis. Besides, berberine 
inhibited the expression of anti-apoptotic factor Bcl-2 but enhanced Beclin-1 expression, 
releasing Beclin-1 from Bcl-2/Beclin-1 complex, and eventually induced autophagy. These 
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results demonstrated that berberine induced both apoptotic and autophagic cell death in liver 
cancer cells. The role of autophagy in cancer cell death is controversial and needs 
classification in particular cases. Some studies reported that autopahgy involved in 
chemotherapeutic agent induced cancer cell death as a pro-survival approach for cancer cell 
[Sy et al., 2008] since autophagy is considered as a self-defensive action when cancer cells 
undergo nutrient starvation, hypoxia and ionizing radiation [Ito, et al., 2005]. While in other 
cases, autophagy may exert self-destructive action and enhance cancer cell death [Kanzawa et 
al., 2003]. In the present study, 3-MA potently attenuated the cytotoxicity of berberine to liver 
cancer cell HepG2 and MHCC97-L (Fig.1B), indicating that both apoptosis and autophagy 
could contribute to cell death in this particular case. Consistent palliative action on the HepG2 
cell death by blocking the autophagosome formation using siRNA against Atg5 gene could be 
observed (Fig.1C and 1D). Since 3-MA was also considered as an apoptosis inhibitor besides 
its inhibition on autophagy, the contribution of autophagic cell death versus apoptosis in 
berberine’s action was calculated by comparing the inhibition rate of 3-MA and Atg5 siRNA 
on the cell death. Up to 30% of cell death was found to be contributed by autophagy induced 
by berberine in HepG2 cells at 250 µM (Fig.1C), and apoptosis contributed the major action 
of berberine on cell death at 250 µM (Fig.1B). 
 
It was noted that berberine used in this study was a relatively high dose. In some cases, the 
IC50 of berberine was lower than 4 µg/mL, which is below the safety limit established by 
National Cancer Institute [Letaˇsiová et al., 2006]. The IC50 of berberine in this study seems 
rather high and the reason needs to be further explored in future. However, berberine is a 
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natural product which has been widely used for many years. As an anti-microbial agent, it has 
been used to cure microbial-related gastric diseases. The dose varies and can be very high, 
even up to 1 gram per day [China Pharmacopeia, 2005 edition]. Our other studies also showed 
that berberine revealed very low cytotoxicity on rat hepatocyte (data not shown) and has liver 
protective effect in liver damage animal model [Ye et al., 2009]. These data suggested 
berberine’s low toxicity and indicated that berberine can be used at high dose. Actually, a 
phase I dose escalation study of Huanglian (Chinese medicines which main active compound 
is berberine) in patients with advanced solid tumours has been conduced at Memorial 
Sloan-Kettering Cancer Center (http://www.cancer.gov/clinicaltrials/ MSKCC-00061) due to 
the potential of berberine and Huanglian in vitro results and Chinese Medicine practice in the 
treatment of cancers [Tang et al., 2009]. New molecular targets, dosage of berberine and cell 
lines used in this study will provide useful information for further study.  
 
Several signal pathways are involved in the regulation of autophagy in cancer cells, including 
Beclin-1, PI3K/Akt/mTOR, death associated protein kinase (DAPK) and Bcl-2 pathways 
[Kondo et al., 2005]. Exogenous expression of Beclin-1 in MCF-7 cells does not 
endogenously generate Belcin-1 initiated autophagy and results in cell death [Liang et al., 
1999].  Besides, some studies reported that Bcl-2 can negatively regulate the Beclin-1 
capacity to induce autophagy by binding to its BH3 domain [Ciechomska et al., 2009]. This 
study revealed that berberine may activate Beclin-1 from Bcl-2/Beclin-1 complexes via 
inhibiting the expression of Bcl-2 (Fig.5A and 5B). Another important mechanism of 
autophagy is the mTOR signaling pathway, which is constantly activated in different kinds of 
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cancers [Vivanco & Sawyers, 2002]. It was demonstrated that TOR kinases is an upstream 
negative regulator for all autophagy-associated genes in yeasts [Wang & Klionsky, 2003]. 
Using rapamycin to inhibit this signaling pathway could induce autophagy and suppress the 
proliferation of cancer cells [Takeuchi et al., 2005], indicating that inhibitor on this pathway 
may contribute to cancer therapy. Since mTOR inhibition in this study has been observed, 
some of the up-streamed pathway of mTOR, including Erk1/2, P38 MAPK and Akt were 
examined. These results found that berberine did not affect Erk1/2 signaling (Data not shown), 
but activated P38 MAPK and inhibited the Akt activity (Fig.5A and 5B). It was suggested that 
the inhibition of berberine on mTOR activity is induced by combination signal of p38 MAPK 
activation and Akt inhibition. In H pG2 cells, significant p38 MAPK activation accelerated 
the mTOR inhibition by berberine, while in MHCC97-L cells, since p38 MAPK did not 
sensitively respond to berberine, the mTOR inhibition was induced solely by berberine’s 
suppression on Akt activity (Fig.5A and 5B). Possible mechanism of berberine-induced 
autophagy in cancer cells is shown in Fig.6. 
 
The relationship between the loss of mitochondria membrane potential and cell apoptosis has 
been extensively studied. Some literature considered that the collapsing of mitochondrial 
inner membrane potential indicates the opening of a large conductance channel, mitochondrial 
permeability transition pore (PT pore), and allows pro-apoptotic signals like Cyto C and 
caspase-activating proteins to release into cytosol [Green & Reed, 1982]. Involvement of Bax 
can be observed during the formation of PT pore [Crompton, 2000].  However, recent 
reports showed that Cyto C and other pro-apoptotic release are Bax-dependent but PT pore 
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formation-independent. The release of Cyto C is actually initiated by the rupture of outer 
mitochondrial membranes (OMM) by Bax activation [Knudson & Brown, 2008] and then gets 
started of apoptosis process in cells. Thus the release of Cyto C and activation of Bax can be 
considered as a mark of mitochondrial apoptosis. However, the regulation and function of PT 
pore formation on mitochondria are in intensive debate. What is clear is that the PT pore 
formation is characterized by the loss of MMP, and that it plays a key role in deciding cell life 
or death [Zorov, et al., 2008]. Bax was also reported to be involved in the formation of PT 
pore [Brenner, et al. 2000], but some also reported a Bax-independent induction of PT pore 
formation [Mullauer, Kessler & Medema, 2009]. In this study, Bax activation and Cyto C 
release were observed, indicating a possible mitochondrial apoptosis in berberine treated 
hepatic cancer cells. A sudden loss of MMP, along with significant cell death in both HepG2 
and MHCC97-L cells treated with berberine was also observed. The exact function and 
mechanism of total abrupt change of mitochondrial induced by berberine need further 
investigation.  
 
In this study, berberine’s potential in apoptotic and autophagic cell death was 
systematically examined though apoptosis induced by berberine and underlying 
mechanism have been previously studied. We observed that apoptotic and autophagic 
cell death were simultaneously induced by berberine in hepatocellular carcinoma cells 
and evidenced by changed biochemical markers in molecular targets and cell signal 
pathways. Based on our result, we found that the total cell death is 20%-80% on 
berberine 100-500 μM (Fig.1B, 3-MA inhibits both apoptotic and autophagic cell 
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death), while autophagic cell death may contribute only 10-25% (Fig.1C and D, Atg5 
siRNA inhibits only autophagic cell death). These results demonstrated that berberine 
has potential to induce both apoptotic and autophagic cell death, in which apoptosis is 
the major type of cell death. However, it may be noted that the cell death inhibitor 
(3-MA) could not fully rescue berberine-induced cell death. It is still unclear if 
autophagic cell death induction of berberine in small proportion is able to play 
significant role in treatment of cancer, but in the following mentioned specific cases, 
combination of berberine with radiotherapy or chemotherapy presented synergistic 
action on cancer cell autophagic and apoptotic cell death, in which berberine’s 
potential in induction of cell death may be enlarged. 5 and 10µM concentrations of 
berberine combined with irradiation significantly strengthened the radio-sensitivity on 
A549 cells was observed, which molecular basis involved in the induction of 
autophagic cell death as well as cell-cycle G2/M arrest [Peng et al., 2008]. The 
synergistic anticancer effect using both As2O3 and berberine was also found in human 
neuroblastoma SH-SY5Y cells and the mechanism was based on the 
mitochondria/caspase-3 dependent signaling pathway [Kim et al., 2007]. At least, we 
got a whole picture of apoptotic and autophagic cell death induced by berberine in 
hepatocellular carcinoma cells in this study and as mentioned above, further 
investigations are required to fully characterize the concomitant mediators and 
determinant switches of cell death induced by berberine or combination with other 
therapies in cancer cell models and animal models. 
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In conclusion, we presented here a novel combined mechanism involved in berberine induced 
cancer cell death, among which apoptosis was the major cell death and autophagic cell death 
was concurrent. Berberine may activate mitochondrial apoptosis in hepatocellular carcinoma 
cells via increasing Bax expression, PT pore formation and Cyto C released to cytosol, and 
subsequently activating caspase-3 and caspase-9 signal pathway. Berberine may also induce 
autophagic cell death via activating Beclin-1 and inhibiting mTOR signaling pathway. We 
provided a whole picture for cell death induced by berberine in hepatocellular carcinoma cells 
and we report for the first time the mechanism of berberine-induced autophagic cell death. As 
a therapeutic agent in the emerging list of alternative cancer therapy, our results shed lights on 
berberine’s potential anticancer with novel mechanism for live cancer. 
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Figure legend  
 
Figure 1. Cytotocixity of berberine in different cancer cells  
A. shows cytotocixity of berberine in HepG2, MHCC97-L, HONE1, HK1 and Hela after 48 
hr treatment. B. shows the viability of HepG2 and MHCC97-L cells after treatment with 
berberine plus or minus 3-MA (10 mM). Residual cell viability following the treatment of 
berberine was significantly decreased in dose-dependent manner. Residual cell viability 
following the treatment of berberine plus 10 mM 3-MA was significant increased. C. shows 
berberine’s cytotoxicity can be attenuated by introducing a siRNA against ATG5 into HepG2 
cells. D. Expression of Atg5 in cells transfected with control or Atg5 siRNA by Western 
bloting (left) and their relative expression by quantitative analysis (right) were shown. All 
experiments were conducted in triplicates and the results were analyzed for statistical 
significance (* p<0.01 when compared with counterpart control; # p<0.01 when compared 
with counterpart berberine-treated only cells). 
 
Figure 2. Berberine induces autophagy in hepatocellular carcinoma cells  
A. shows autophagosome formation after 6 hr treatment of berberine and berberine plus 
3-MA using MDC staining. Microscopic photos were taken at 630×magnification (upper 
panel) and percentage of cells with positive staining was calculated (lower panel). B. shows 
the lysosome accumulation after 6 hr treatment of berberien and berberine plus 3-MA using 
AOs staining. Microscopic photos were taken at 630×magnification (upper panel) and 
percentage of cells with positive staining was calculated (lower panel). C. shows immunoblot 
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analysis of LC3-I (18 kDa) and LC3-II (16 kDa). Fifteen micrograms of cell lysates from 
HepG2 (left) or MHCC97-L (right) were subjected to Western blot analysis using LC3B 
antibody (upper panel) and the relative expression of LC3-II protein was calculated (lower 
panel). D. shows that berberine could induce GFP-LC3 fusion protein accumulation in HepG2 
cells nucleofected with pcDNA3 plasmid encoding GFP-LC3 at 630×magnification (left) and 
percentage of cells with autophagy puncta (right). Relative expression of Atg5 in cells 
transfected with control or Atg5 siRNA was shown in Fig. 1D. E shows the expression of 
LC3-I and LC-II in HepG2 cells exposed to berberine (200 µM) or vehicle in the presence of 
bafilomycin A1 (32 nM) (* p<0.05, **p<0.01 when compared with counterpart control; # 
p<0.05, ##p<0.01 when compared with counterpart berberine-treated only cells). 
 
Figure 3. Berberine induces apoptosis in hepatocellular carcinoma cells 
A. HepG2 and MHCC97-L cells were stained with Annexin V (0.5 µg/mL) and PI (2µg/mL) 
after 12 hr treatment of berberine for FACS analysis. B. quantitative data shows berberine 
induces HepG2 (left) and MHCC97-L (right) cells apoptosis in dose-dependent manner. All 
experiments were conducted in triplicates and the results were analyzed for statistical 
significance (* p<0.05, ** p<0.01, ***p<0.001, **** p<0.0001 when compared with 
counterpart control)  
 
Figure 4 Berberine induced mitochondrial apoptosis in hepatocellular carcinoma cells 
A. shows the decrease of mitochondrial membrane potential after 12 hr treatment of berberine 
or vehicle in HepG2 and MHCC97-L cells. Microscopic photos were taken at 630× 
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magnification. B. shows the quantitative analysis of fluorescent signal drop with increase of 
berberine’s concentration (stained by Rh-123) in HepG2 and MHCC97-L cells. C. shows the 
mitochondrial apoptosis pathway related protein expression in HepG2 and MHCC97-L cells 
with treatment of berberine or vehicle by Western blot analysis. D. shows quantitative 
analysis for relative protein expression in C. All experiments were conducted in triplicates. (* 
p<0.05, **p<0.01 when compared with counterpart control). 
 
Figure 5. Autophagy related signal transduction in hepatocellular carcinoma cells with 
or without treatment of berberine 
A. HepG2 and MHCC97-L cells w re treated with indicating dosages of berberine for 6 hr, 
and fifteen micrograms of cell lysates from HepG2 cells (left) and MHCC97-L cells (right) 
were subjected to western blot analysis using related antibodies. B. shows quantitative 
analysis for relative protein expression in A. All experiments were conducted in triplicates. (* 
p<0.05, **p<0.01 when compared with counterpart control). 
 
Figure 6. Possible mechanism involved in berberine-regualting autophagy in liver cancer 
cells 
The schematic signaling patterns display that Bcl-2/Beclin-1 complexes and PI3K/Akt/mTOR 
signaling pathway are modulated by berberine in regualting autophagy in liver cancer cells. 
Our study revealed that berberine may activate Beclin-1 from Bcl-2/Beclin-1 complexes via 
inhibiting the expression of Bcl-2 and on the other hand, inhibition of mTOR by berberine 
responsible for the inhibition of Akt and activation of P38 MAPK may initiate autophagy. 
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Berberine makes both signaling pathways work together to enhance authophagy in hepatoma 
cells. 
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Figure 1. Cytotocixity of berberine in different cancer cells  
A. shows cytotocixity of berberine in HepG2, MHCC97-L, HONE1, HK1 and Hela after 48 hr 
treatment. B. shows the viability of HepG2 and MHCC97-L cells after treatment with berberine plus 
or minus 3-MA (10 mM). Residual cell viability following the treatment of berberine was significantly 
decreased in dose-dependent manner. Residual cell viability following the treatment of berberine 
plus 10 mM 3-MA was significant increased. C. shows berberine’s cytotoxicity can be attenuated by 
introducing a siRNA against ATG5 into HepG2 cells. D. Expression of Atg5 in cells transfected with 
control or Atg5 siRNA by Western bloting (left) and their relative expression by quantitative analysis 
(right) were shown. All experiments were conducted in triplicates and the results were analyzed for 
statistical significance (* p<0.01 when compared with counterpart control; # p<0.01 when 
compared with counterpart berberine-treated only cells).  
160x277mm (300 x 300 DPI)  
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Figure 2. Berberine induces autophagy in hepatocellular carcinoma cells  
A. shows autophagosome formation after 6 hr treatment of berberine and berberine plus 3-MA using 
MDC staining. Microscopic photos were taken at 630×magnification (upper panel) and percentage of 
cells with positive staining was calculated (lower panel). B. shows the lysosome accumulation after 
6 hr treatment of berberien and berberine plus 3-MA using AOs staining. Microscopic photos were 
taken at 630×magnification (upper panel) and percentage of cells with positive staining was 
calculated (lower panel). C. shows immunoblot analysis of LC3-I (18 kDa) and LC3-II (16 kDa). 
Fifteen micrograms of cell lysates from HepG2 (left) or MHCC97-L (right) were subjected to Western 
blot analysis using LC3B antibody (upper panel) and the relative expression of LC3-II protein was 
calculated (lower panel). D. shows that berberine could induce GFP-LC3 fusion protein accumulation 
in HepG2 cells nucleofected with pcDNA3 plasmid encoding GFP-LC3 at 630×magnification (left) and 
percentage of cells with autophagy puncta (right). Relative expression of Atg5 in cells transfected 
with control or Atg5 siRNA was shown in Fig. 1D. E shows the expression of LC3-I and LC-II in 
HepG2 cells exposed to berberine (200 µM) or vehicle in the presence of bafilomycin A1 (32 nM) (* 
p<0.05, **p<0.01 when compared with counterpart control; # p<0.05, ##p<0.01 when compared 
with counterpart berberine-treated only cells).  
160x106mm (300 x 300 DPI)  
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Figure 3. Berberine induces apoptosis in hepatocellular carcinoma cells 
A. HepG2 and MHCC97-L cells were stained with Annexin V (0.5 µg/mL) and PI (2µg/mL) after 12 hr 
treatment of berberine for FACS analysis. B. quantitative data shows berberine induces HepG2 (left) 
and MHCC97-L (right) cells apoptosis in dose-dependent manner. All experiments were conducted in 
triplicates and the results were analyzed for statistical significance (* p<0.05, ** p<0.01, 
***p<0.001, **** p<0.0001 when compared with counterpart control)  
160x103mm (300 x 300 DPI)  
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Figure 4 Berberine induced mitochondrial apoptosis in hepatocellular carcinoma cells 
A. shows the decrease of mitochondrial membrane potential after 12 hr treatment of berberine or 
vehicle in HepG2 and MHCC97-L cells. Microscopic photos were taken at 630× magnification. B. 
shows the quantitative analysis of fluorescent signal drop with increase of berberine’s concentration 
(stained by Rh-123) in HepG2 and MHCC97-L cells. C. shows the mitochondrial apoptosis pathway 
related protein expression in HepG2 and MHCC97-L cells with treatment of berberine or vehicle by 
Western blot analysis. D. shows quantitative analysis for relative protein expression in C. All 
experiments were conducted in triplicates. (* p<0.05, **p<0.01 when compared with counterpart 
control).  
160x187mm (300 x 300 DPI)  
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Figure 5. Autophagy related signal transduction in hepatocellular carcinoma cells with or without 
treatment of berberine 
A. HepG2 and MHCC97-L cells were treated with indicating dosages of berberine for 6 hr, and fifteen 
micrograms of cell lysates from HepG2 cells (left) and MHCC97-L cells (right) were subjected to 
western blot analysis using related antibodies. B. shows quantitative analysis for relative protein 
expression in A. All experiments were conducted in triplicates. (* p<0.05, **p<0.01 when 
compared with counterpart control).  
160x148mm (300 x 300 DPI)  
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Figure 6. Possible mechanism involved in berberine-regualting autophagy in liver cancer cells 
The schematic signaling patterns display that Bcl-2/Beclin-1 complexes and PI3K/Akt/mTOR 
signaling pathway are modulated by berberine in regualting autophagy in liver cancer cells. Our 
study revealed that berberine may activate Beclin-1 from Bcl-2/Beclin-1 complexes via inhibiting the 
expression of Bcl-2 and on the other hand, inhibition of mTOR by berberine responsible for the 
inhibition of Akt and activation of P38 MAPK may initiate autophagy. Berberine makes both signaling 
pathways work together to enhance authophagy in hepatoma cells.  
160x181mm (400 x 400 DPI)  
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